Company Filing History:
Years Active: 1998-1999
Title: Innovations by Lane L Clarke
Introduction
Lane L Clarke is an accomplished inventor based in Columbia, MO (US). He has made significant contributions to the field of medical treatments, particularly in addressing cystic fibrosis. With a total of 2 patents, Clarke's work focuses on innovative methods to enhance the function of cystic fibrosis transmembrane conductance regulator (CFTR) in affected individuals.
Latest Patents
Clarke's latest patents include a method for treating cystic fibrosis by generating CFTR function in cells containing mutant CFTR. This method involves administering an effective amount of genistein, or its analogues and derivatives, to individuals afflicted with cystic fibrosis. Another notable patent describes peptides derived from mutant CFTR protein that inhibit intracellular degradation and retention of these proteins. This method aims to prevent the degradation of synthesized mutant proteins before they reach the cell surface.
Career Highlights
Clarke is affiliated with the University of Missouri, where he conducts his research and develops his innovative treatments. His work has the potential to significantly improve the quality of life for those suffering from cystic fibrosis.
Collaborations
Clarke collaborates with esteemed colleagues, including Elmer M Price and Tzyh-Chang Hwang, who contribute to his research endeavors.
Conclusion
Lane L Clarke's innovative approaches to treating cystic fibrosis highlight his dedication to advancing medical science. His patents reflect a commitment to improving patient outcomes through targeted therapies.